National Genomics Directories for Somatic and Inherited Cancers
The 2020/2021 National Genomic Test Directory for Cancer specifies the genomic tests commissioned by the NHS in England for cancer, the technology by which they are available, and the patients who will be eligible to access testing. The Genomic Test Directory for Cancer is sub-divided into Adult Solid Tumours, Neurological Tumours, Sarcomas, Haematological Cancer and Paediatric Tumours.
The majority of tests within the Genomic Test Directory for Cancer are available within the Central and South Genomic Laboratory Hub (C&S GLH). Some specialised tests will be exported to other GLH laboratories within the Genomic Medicine Service network. Tests which are not listed on the Test Directory are not currently commissioned by NHS England. The process for requesting additions and updates to the Test Directory is detailed here.